Page last updated: 2024-10-24

negative regulation of sensory perception of sweet taste

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of sensory perception of sweet taste. [GO_REF:0000058, GOC:mr, GOC:TermGenie, PMID:1716172]

Negative regulation of sensory perception of sweet taste involves a complex interplay of cellular and molecular mechanisms. It begins with the detection of sweet tastants by taste receptor cells (TRCs) located on the tongue. These TRCs express G protein-coupled receptors (GPCRs), primarily the heterodimer of T1R2 and T1R3, which bind to sweet molecules and initiate a signaling cascade. Upon binding, the T1R2/T1R3 receptor activates the G protein gustducin, leading to the production of the second messenger inositol trisphosphate (IP3). IP3 triggers the release of calcium ions (Ca2+) from intracellular stores, initiating a depolarization of the TRC membrane. This depolarization propagates to nearby neurons, sending a signal to the brain that is interpreted as sweetness.

However, constant exposure to sweet tastes would desensitize the system, leading to a diminished sweet perception. To counteract this, various mechanisms are involved in negative regulation of sweet taste perception:

1. **Desensitization of Taste Receptors:** Sweet taste receptors can undergo desensitization after prolonged exposure to sweet tastants. This occurs through several mechanisms:
* **Phosphorylation:** Receptor kinases can phosphorylate the T1R2/T1R3 receptor, leading to its internalization and degradation.
* **Endocytosis:** The receptors can be internalized through endocytosis and sequestered away from the cell surface, reducing their availability for ligand binding.
* **G protein uncoupling:** The G protein gustducin can be uncoupled from the activated receptor, preventing further signaling.

2. **Regulation of Intracellular Signaling:** The downstream signaling pathways can also be regulated to attenuate the sweet taste signal:
* **IP3 degradation:** Phosphatases can break down IP3, reducing its availability to activate Ca2+ release.
* **Calcium buffering:** Cellular mechanisms can buffer the increase in Ca2+ levels, preventing excessive depolarization of the TRC.
* **Activation of inhibitory pathways:** The signaling cascade can activate inhibitory pathways, such as the G protein-coupled receptor kinase (GRK) pathway, which can attenuate the sweet taste response.

3. **Adaptation at the Neuronal Level:** At the neuronal level, adaptation can occur to reduce the sensitivity to sweet stimuli:
* **Synaptic depression:** The release of neurotransmitters from taste neurons can be reduced through synaptic depression, diminishing the signal transmission to the brain.
* **Modulatory neurons:** Specialized neurons can release neurotransmitters that inhibit the transmission of sweet taste signals to the brain.

These negative regulatory mechanisms ensure that the sweet taste system remains responsive to changes in sweetness levels and prevents habituation to constant sweet stimuli. The fine-tuned balance between stimulatory and inhibitory pathways allows for the perception of a wide range of sweet tastes, from subtle sweetness to intense sweetness. '
"

Proteins (1)

ProteinDefinitionTaxonomy
Riboflavin-binding proteinA protein that is a translation product of the RTBDN gene in chicken. [PRO:DNx, UniProtKB:P02752]Gallus gallus (chicken)

Compounds (4)

CompoundDefinitionClassesRoles
quinacrinequinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
chloroquinechloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
lumiflavinlumiflavin : A compound showing yellow-green fluorescence, formed by a photolysis of riboflavin in alkaline solution.flavin
riboflavinvitamin B2 : Any member of a group of vitamers that belong to the chemical structural class called flavins that exhibit biological activity against vitamin B2 deficiency. Symptoms associated with vitamin B2 deficiency include glossitis, seborrhea, angular stomaitis, cheilosis and photophobia. The vitamers include riboflavin and its phosphate derivatives (and includes their salt, ionised and hydrate forms).flavin;
vitamin B2
anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite